212 related articles for article (PubMed ID: 31810423)
1. Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.
Kurtti A; Fritz K; Elofson-Disney K; Benefield R
J Oncol Pharm Pract; 2020 Sep; 26(6):1301-1305. PubMed ID: 31810423
[TBL] [Abstract][Full Text] [Related]
2. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the incidence of febrile neutropenia in obese and normal weight breast cancer patients receiving myelosuppressive chemotherapy and prophylactic pegfilgrastim.
Collins JM; Fleming GF; Christ TN
J Oncol Pharm Pract; 2019 Jul; 25(5):1112-1118. PubMed ID: 29768957
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Lee P; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
[TBL] [Abstract][Full Text] [Related]
5. [Levofloxacin prophylaxis in neutropenic patients].
Carena AA; Jorge L; Bonvehí P; Temporiti E; Zárate MS; Herrera F
Medicina (B Aires); 2016; 76(5):295-303. PubMed ID: 27723617
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia].
Hata A; Katakami N; Masuda Y; Takashima K; Takeshita J; Tanaka K; Kaji R; Fujita S; Ose T; Kitajima N
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1119-23. PubMed ID: 25248895
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Monahan I; Karunanithi K; Dignum H; Belsham E; Neilson J; Harrison B; Lokare A; Campbell G; Hamblin M; Hawkey P; Whittaker AC; Low E; Dunn JA;
Lancet Oncol; 2019 Dec; 20(12):1760-1772. PubMed ID: 31668592
[TBL] [Abstract][Full Text] [Related]
10. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
13. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
Lote H; Sharp A; Redana S; Papadimitraki E; Capelan M; Ring A
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):597-603. PubMed ID: 26936608
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Aoki T; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2014; 9(1):e85210. PubMed ID: 24465506
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Use Of Levofloxacin During Induction Of Acute Lymphoblastic Leukaemia In Children-Experience From Pakistan.
Rehman P; Shaukat Z; Saeed H; Raza A; Anjum S; Wali RM
J Pak Med Assoc; 2023 Oct; 73(10):2065-2068. PubMed ID: 37876072
[TBL] [Abstract][Full Text] [Related]
16. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
[TBL] [Abstract][Full Text] [Related]
19. Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.
Chen C; Chan A; Yap K
J Oncol Pharm Pract; 2013 Jun; 19(2):111-20. PubMed ID: 23014897
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
Owattanapanich W; Chayakulkeeree M
Hematology; 2019 Dec; 24(1):362-368. PubMed ID: 30880638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
